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Abstract
Telomeres are nucleoprotein structures located at the linear ends of eukaryotic chromosomes. Telomere integrity is required
for cell proliferation and survival. Although the vast majority of eukaryotic species use telomerase as a primary means for
telomere maintenance, a few species can use recombination or retrotransposon-mediated maintenance pathways. Since
Saccharomyces cerevisiae can use both telomerase and recombination to replicate telomeres, budding yeast provides a
useful system with which to examine the evolutionary advantages of telomerase and recombination in preserving an
organism or cell under natural selection. In this study, we examined the life span in telomerase-null, post-senescent type II
survivors that have employed homologous recombination to replicate their telomeres. Type II recombination survivors
stably maintained chromosomal integrity but exhibited a significantly reduced replicative life span. Normal patterns of cell
morphology at the end of a replicative life span and aging-dependent sterility were observed in telomerase-null type II
survivors, suggesting the type II survivors aged prematurely in a manner that is phenotypically consistent with that of wild-
type senescent cells. The shortened life span of type II survivors was extended by calorie restriction or TOR1 deletion, but
not by Fob1p inactivation or Sir2p over-expression. Intriguingly, rDNA recombination was decreased in type II survivors,
indicating that the premature aging of type II survivors was not caused by an increase in extra-chromosomal rDNA circle
accumulation. Reintroduction of telomerase activity immediately restored the replicative life span of type II survivors despite
their heterogeneous telomeres. These results suggest that telomere recombination accelerates cellular aging in telomerase-
null type II survivors and that telomerase is likely a superior telomere maintenance pathway in sustaining yeast replicative
life span.
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Introduction
Telomeres are the physical ends of linear eukaryotic chromo-
somes and are composed of specific repetitive DNA sequences and
binding proteins [1,2]. The functional integrity of telomeres is
required for cell proliferation and survival because they protect
chromosome ends from nucleolytic degradation and help to
distinguish normal chromosome ends from DNA double-strand
breaks [3–5]. Additionally, telomeres can compensate for the
incomplete replication of chromosomal DNA by conventional
DNA polymerases [6,7].
In eukaryotes, telomeres can be maintained by three different
mechanisms, namely a telomerase-dependent pathway, a recombi-
nation pathway and a retrotransposon-mediated transposition
pathway [8,9]. Telomerase-dependent telomere replication has
beendocumentedinthevastmajorityofeukaryoticspeciesincluding
in budding yeast and humans. In these species, repetitive telomeric
DNA is added to the chromosome ends by telomerase, a specialized
reverse transcriptase that catalyzes the addition of telomeric DNA
using its intrinsic RNAtemplate [10,11]. Recombination-dependent
telomere maintenance has been reported in a few organisms that
naturally lack telomerase, including the lower dipterans Chironomus
and Anopheles and the plant Allium spp [12–14]. Retrotransposon-
mediated telomere maintenance has been well adapted by the fruit
fly Drosophila melanogaster [15–18]. The wider use of telomerase in
eukaryotes suggests that it has been evolutionarily selected for as an
advantageous mechanism for maintaining telomere integrity and
stability, however, the reasons why telomerase has been adopted by
so many eukaryotic species are not clear.
Interestingly, some organisms are likely capable of using both
telomerase and recombination to replicate their telomeres. For
example, previous studies have reported that 85% of the human
cancer cells are telomerase positive, however the other 15% cancer
cells are telomerase negative [19] and maintain their telomeres by
recombination pathway, also termed alternative lengthening of
telomeres (ALT) [20]. In the budding yeast Saccharomyces cerevisiae,a
RAD52-dependent homologous recombination pathway can be
employed by a minority of telomerase-negative cells as an
alternative method for telomere maintenance. These cells are
called post-senescent survivors. Two types of post-senescent
survivors exist and are distinguishable by their characteristic
telomere patterns. Type I survivors exhibit amplification of Y’
elements and have very short TG1–3 repetitive tracts on the
chromosome ends [21]. Type II survivors show a variable pattern
of long tracts of TG1–3 repeats and only modest Y’ amplification
[22]. Because type II survivors have long and heterogeneous
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RAD50 and RAD52, they resemble human ALT cells [20,23–25].
In budding yeast, telomerase seems to be the preferential telomere-
elongation pathway. Introduction of the telomerase component
EST1 back into an est1D type I survivor that exhibits extensive Y’
amplification results in the elongation of the terminal telomeric
tract back to wild-type length, as well as a substantial reduction in
Y’ copy number [21,22]. Similarly, following reintroduction of
telomerase into a type II survivor, telomeres gradually return to a
wild-type telomeric structure that can be confirmed by examining
telomeric restriction patterns via Southern blotting [22].
To investigate whether recombination is inferior to telomerase
in preserving an organism or cell under natural selection, we
compared cellular traits in telomerase-null post-senescent type II
survivor cells to cellular traits in telomerase positive cells. Type I
recombination survivors were not included in this report because
they have a severe growth defect and highly abnormal karyotypes
[21,26]. In this report we demonstrate that recombination was as
efficient as telomerase in maintaining cell survival and overall
genome stability, but telomerase-null cells using recombination-
only maintenance of telomeres had a shortened replicative life
span (RLS) when compared to telomerase-positive cells. In yeast,
RLS is defined as the total number of daughter cells generated by
a mother cell before cell death [27]. RLS was significantly reduced
in type II survivors. The decline in RLS was not due to a defect in
the canonical aging regulation pathways and the reintroduction of
telomerase activity immediately restored the RLS of type II
survivors to that of a wild type cell. Our results provide
experimental evidence supporting the notion that telomerase is
superior to telomere recombination in the regulation of yeast
replicative life span.
Results
Telomere recombination is as efficient as telomerase in
maintaining cell survival
To determine whether the recombination pathway is as efficient
as the telomerase pathway in maintaining cell survival, we mated
either type II survivors (ALT II pathway in humans) or
telomerase-proficient cells (TERT pathway in humans) with yeast
cells whose telomerase was recently inactivated (pre-survivors,
SEN) (Figure 1A). The viability of the resulting diploids was
examined. Diploids generated by crossing two SEN populations
senesced and underwent crisis (Figure 1A, sectors 3 and 4). In
contrast, diploids generated by crossing a type II survivor with a
SEN (Figure 1A, sectors 5 and 6) grew as vigorously as the diploids
created by mating a TERT with a SEN (Figure 1A, sectors 1 and
2). These data are consistent with previous reports [28] and
suggest that telomere maintenance by recombination is as efficient
as telomere maintenance by telomerase in maintaining cell
survival.
Telomerase-null type II survivors are able to stably
maintain their chromosomes
Genome integrity is maintained in telomerase-proficient cells
because telomeres are not recognized as DNA double-strand
breaks [3]. To ascertain if genome stability was altered in
telomerase-negative type II survivors, we carried out several
phenotypic analyses and compared our results to those obtained
from telomerase-positive (wild-type) cells. First, we determined
that type II survivor cells grew as robustly as the wild-type cells
(Figure 1B) [22]. Second, we found that type II survivors exhibited
similar levels of sensitivity to four separate DNA damage-inducing
agents when compared to wild-type cells (Figure 1B). Third,
telomere position effect (TPE), a silencing mechanism combining
telomere architecture and classical heterochromatin features, was
slightly enhanced in type II survivor cells, indicating that the
heterochromatic state of telomeres has not been damaged
(Figure 1C). This observation was consistent with previous reports
where increasing the length of telomeres was found to enhance
TPE [29–31]. Fourth, normal telomere positioning at the nuclear
periphery was maintained in type II survivors, as shown by
immunostaining of the telomeric repeat binding protein Rap1p
(Figure 1D). Fifth, pulsed-field gel electrophoresis revealed that
haploid type II survivors contained linear chromosomes that were
indistinguishable from wild-type cells (Figure 1E). Finally, the
gross-chromosomal rearrangement (GCR) analyses showed that
the type II survivors had a very low GCR rate, in contrast with the
rad50D mutants that displayed a significant increase of GCR
events (Figure 1F). This behavior of the type II survivors was
similar to that seen in wild-type cells as previously reported
(Figure 1F) [32]. These results suggested that the elevated
recombination at type II survivor telomeres has not caused any
noticeable defects in DNA replication or repair, and the
chromosomes of the type II survivors are stably maintained.
Telomerase-null type II survivors age prematurely
A link between an increase of repetitive rDNA recombination
and cellular aging has been well established in S.cerevisiae [33].
With the activation of homologous recombination at telomeric
repeats, the type II survivor cells showed more heterogeneous
lengths of telomeric TG1–3 tracts and modest Y’ telomere
amplification (Figure 2A) [22]. Conversely, DNA instability was
not observed in another part of the genome when gross
chromosomal rearrangements were examined in type II survivors
(Figure 1F). This discontinuity of results led us to wonder if the
replicative capacity of the type II survivors was comparable to that
of telomerase-positive cells. A population of budding yeast cells,
can be grown indefinitely in culture under optimal conditions
using either telomerase or recombination for telomere mainte-
nance (Figure 1A) [21,22]. However, the replicative capacity of a
single yeast cell is finite. This is because of the activity of other
Author Summary
Telomeres are the specialized structures at the ends of
eukaryotic linear chromosomes. The simple guanine-rich
DNA repeats at telomeres and their associated proteins are
important for chromosome stability. Most eukaryotic
species have evolved an enzyme named telomerase to
replicate their telomeric DNA. Telomerase usually contains
a protein catalytic subunit and a RNA template subunit. A
few eukaryotic species can use either telomere recombi-
nation or retrotransposon-mediated transposition to ac-
complish telomere elongation. Interestingly, the baker’s
yeast Saccharomyces cerevisiae can use both telomerase
and recombination to replicate telomeres. In this study, we
utilize this unique eukaryotic model system to compare
the efficiency of these two mechanisms in the mainte-
nance of cellular function and life span. Telomerase-null
cells that used recombination to elongate telomeres were
able to maintain relatively stable chromosomes; however,
they exhibited a shortened replicative life span which may
represent a novel aging pathway. Reintroduction of
telomerase inhibited telomere recombination and restored
the replicative life span of these cells, implying that
telomerase is superior to telomere recombination in the
regulation of yeast replicative life span.
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whether the telomeres are maintained by telomerase or by
recombination throughout the life span [33,34]. Since yeast cells
reproduce by asymmetric cell division with a larger mother cell
giving rise to a smaller daughter cell, the two cells can be separated
right after each cell division by micromanipulation. The number
of daughter cells that a mother cell can produce before senescence
defines the replicative life span of that cell. The average number of
cell divisions undergone by a group of mother cells defines the
mean replicative life span of a yeast strain [27,35]. A young cell
will become mother cell after production of its first daughter.
Replicative life span (RLS) analysis showed that the mean life
span of the type II survivors was 15.3 generations, which was
much shorter than 27.8 generations of wild-type cells (Figure 2A).
Apparently, the reduction in the replicative capacity of type II
survivors was neither mating-type nor strain-specific (Figure S1A,
S1B). Consistently, the type II survivor cells derived from deletion
of the telomerase subunit EST3 also showed significantly
decreased life span (Figure S1C). Previous studies showed that,
type II survivors are stable over time, but their telomeres
experience a cycle of continuous shortening and abrupt elongation
during the outgrowth (Figure 2B) [22]. To determine whether the
accelerated cellular senescence persists during the outgrowth, we
analyzed the life span of the 1
st-, 10
th-, and 25
th-restreaked type II
survivors. All these survivors exhibited significantly reduced life
span, despite the changes in telomere length (Figure 2B). Thus, for
the first time, a severely reduced life span was observed in the
telomerase-null type II survivors.
As previously reported, critically short telomere(s) cause
telomerase-deficient cells to abruptly cease cell division, and
senesce at the G2/M checkpoint (Figure S2) [36]. To determine
whether the accelerated senescence of type II survivors was caused
by critically short telomere(s), the morphology of cells at the end of
their life span was indexed according to a previously established
method where the fraction of unbudded, small-budded, and large-
budded cells is determined [37]. In our experiments, the large-
budded proportion of old type II cells was comparable to that of
old wild-type cells (Figure 2C), suggesting that type II survivors
may age by a process that is independent of critically-short-
telomeres.
Long telomeres have also been proposed to affect replicative life
span. For example, rif1D cells have much longer telomeres than
wild-type cells and their replicative life span is reduced [38]. These
data with rif1D cells led to the generation of a hypothesis that long
telomeres may reduce life span by competing for Sir silencing
factors with the non-telomeric loci [38,39]. Because the telome-
rase-null type II survivors possess long and heterogeneous
telomeres, it is possible that long telomeres per se in these cells
result in the life span decline. To test this possibility, yeast cells that
harbored long telomeres by temporarily over-expressing telome-
rase were subject to a life span assay. Results show that these cells
had regular life span (Figure 2E), indicating that long telomeres
per se may not be the direct cause of the shorter life span we saw in
the type II survivors.
To confirm that the telomerase-null type II survivors died of
replicative aging but not general sickness, we examined age-
dependent sterility in type II survivors. Sterility due to loss of
silencing at HMLa and HMRa loci has been reported as an aging-
specific phenotype in budding yeast [40,41]. We determined the
percentage of sterile cells as cells aged by documenting the
inability of cells to respond to a mating pheromone, a factor.
Similar to the wild-type cells, type II survivors became sterile at a
higher frequency the older they got (Figure 2D). Together, the
data from all the phenotypic assays in the section led us to
conclude that telomerase-null type II survivors aged prematurely
in a manner that was phenotypically indistinguishable from that of
telomerase-positive wild-type cells.
The life span of type II survivors can be extended by
calorie restriction or by inactivation of the TOR pathway
Calorie restriction (CR) is an intervention which slows the aging
process and increases life span in many organisms [42]. In yeast,
CR can be executed by reducing the glucose concentration of
growth media from 2% to 0.5% (or 0.05%), resulting in a
significant increase of life span (Figure 3A) [43,44]. Life span
extension by CR in yeast involves at least three nutrient-responsive
kinases: TOR (target of rapamycin), Sch9, and protein kinase A
(PKA) [43,45–47]. To better understand life span regulation in
type II survivor cells, we examined whether these canonical aging
pathways function in type II survivors. Although type II survivors
exhibited accelerated replicative aging, CR (in 0.05% glucose)
significantly extended the survivors’ life span from 12.6 to 16.7
generations (Figure 3A). The deletion of TOR1 also significantly
extended the mean and maximum life span of type II survivors
(Figure 3B). Subsequently, we found that the inactivation of Tor1
affected neither the senescence nor survivor-arising rate of est2D
cells (Figure S3). In addition, tor1D type II survivors exhibited
shorter life span than that of tor1D telomerase-positive cells
(Figure 3B). Based on these data, we propose that TOR1 regulates
the replicative life span of type II survivors independently of
telomere recombination. The extension of life span by either
calorie restriction or Tor1 deletion further indicated that type II
survivors are not simply sick cells.
Lack of telomerase capping does not directly cause the
decline of replicative life span
In every way we examined them phenotypically, type II
survivors seemed to resemble wild-type cells with the exception
that their telomeres were elongated through telomere-telomere
recombination and not telomerase (Figure 2A). Because telome-
rase has been suggested to play a role in capping of telomeres and
facilitating cell proliferation [48], there is a possibility that the lack
of telomerase capping provides an essential senescence signal.
Alternatively, the increased telomere recombination per se in
telomerase-null survivors induced chromosomal instability at
telomere and this may be the cause of the decreased life span.
To distinguish between these two possibilities, we examined the
RLS of telomerase-deficient pre-survivors. Heterozygous yeast
diploid cells with a single EST2 deletion were dissected and
subjected to serial restreaking on YPD plates every 48 hours. Both
the spores taken immediately from the tetrad dissection and the
Figure 1. Phenotypic analyses of BY4742 est2D type II survivors. (A) Cell growth of diploids derived from crosses between: SEN est2D cells
and SEN est2D cells (sectors 3, 4, negative control for senescence), SEN est2D cells and TERT telomerase positive cells (sectors 1, 2), SEN est2D cells and
ALT II est2D strains (sectors 5, 6). (B) DNA damage sensitivity assay with est2D type II survivors. (C) Telomere position effect assay of est2D type II
survivors. The sir2D strain serves as a positive control. (D) Immunostaining of the telomeric repeat binding protein Rap1p (Red) in est2D type II
survivors. Blue, DAPI staining of DNA. (E) Pulsed-field gel electrophoresis (PFGE) analysis of karyotypes in est2D type II survivors. Each lane represents
an independent clone. (F) Gross chromosomal rearrangement (GCR) analysis. Mean and standard deviation (S.D.) rates collected from three
independent experiments are shown. The rad50D strain serves as a positive control for increased GCRs.
doi:10.1371/journal.pgen.1000535.g001
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PLoS Genetics | www.plosgenetics.org 4 June 2009 | Volume 5 | Issue 6 | e1000535Figure 2. Premature aging of telomerase-null type II survivors. (A) Telomere analysis (left) and life span assay (right) of telomerase-null type II
survivors. The number of daughter cells (generations) produced per mother cell are plotted as a function of mother cell viability. Average life span of
strains shown (sample size): BY4741, 27.869.7 (n=60); est2D-type II (MATa), 15.368.5 (n=57). (B) Changes of telomeres (left) and life span (right) in
type II survivors during the outgrowth. Type II survivors were serially restreaked 25 times on YPD plates. (Left) Genomic DNA from the 1
st,5
th,1 0
th,
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life span (Figure 4A and 4B). Decreased RLS was only observed in
telomerase-null pre-survivors during the later serial restreaks when
there was severe loss of telomeric DNA (Figure 4C). Reintroduc-
tion of telomerase restored the low RLS of pre-survivors by
elongation of short telomeres, suggesting that the short RLS of late
passages was caused by critically short telomere(s) (Figure 4C).
Together, these data supported a model where the absence of
Est2p did not directly cause a reduction in replicative capacity and
the shorter life span of type II survivors was not caused by the lack
of telomerase capping.
The observation of loss-of-productivity in late passages of
telomerase-null pre-survivors mirrors what is known to happen to
est2D cells on serial streak-outs (Figure 1A), or in liquid-growing
culture (Figure S2A) [36,49]. Mother cells exhibited the same rate
of cell viability reduction as the logarithmically growing cells, the
vast majority of which are young cells, suggesting that the older
mother cells and younger cells do not have appreciable difference
in their ability to maintain telomeres in the absence of
telomerase.
Reintroduction of telomerase activity restores the life
span of type II survivor cells
In budding yeast, telomerase appears to be the preferred
pathway for telomere maintenance [21,22]. To examine whether
reintroducing telomerase activity in survivors may inhibit
telomere recombination and rescue the short RLS, we performed
a mating assay in which est2D type II survivor cells (MATa)w e r e
mated with wild-type cells (MATa). The telomerase-positive
diploids (named ‘‘survivor diploids’’) had a heterogeneous
telomere-length (Figure 5A). However, they possessed similar
replicative capacity to the wild-type diploids (Figure 5A),
indicating that telomerase is dominant over recombination in
regulating cellular life span, and further suggesting that
heterogeneous long-telomeres are not the cause of premature
aging. The diploid cells in this background (BY4743) lived
significantly longer than haploid cells, and this phenomenon was
also observed by Kaeberlein et al. [50]. Next, both the telomerase-
negative and positive haploid cells were obtained by tetrad
dissection from the ‘‘survivor diploids’’. Interestingly, all the
spores had long heterogeneous telomeres but possessed the same
replicative capacity as the wild-type haploids (Figure 5B). These
results are supportive of the following conclusions: (i) reintroduc-
tion of telomerase activity is able to extend the short RLS of type
II survivors; (ii) the reduced replicative capacity of telomerase-
null type II survivors resulted from telomere alteration; (iii) lack of
telomerase capping does not cause a decline of replicative
capacity, consistent with the results shown in Figure 4; (iv) long
telomeres per se do not affect cellular life span, consistent with
our previous results shown in Figure 2E; (v) telomerase may
restore RLS by inhibiting telomere recombination rather than
regulating telomere length.
To further verify the idea that reintroducing telomerase
activity into survivors may inhibit telomere recombination and
rescue the cellular life span, we reintroduced EST2 into the type
II survivors which were originally derived from cells with an
EST2 deletion. Reintroduction of telomerase activity caused a
gradual shortening of very long telomeres in type II survivors,
Figure 3. Calorie restriction or inactivation of the TOR pathway
extends the life span of type II survivors. (A) Calorie restriction in
est2D type II survivors. Mean life span of strains shown: BY4742-2%
Glucose, 23.669.3 (n=56); BY4742-0.05% Glucose, 30.569.2 (n=53);
est2D type II-2% Glucose, 12.668.0 (n=60); est2D type II-0.05% Glucose,
16.767.2 (n=60). (B) Life span analysis in est2D type II survivors with
TOR1 deletion. Mean life span of strains shown: BY4742, 24.8611.1
(n=60); tor1D, 29.4612.9 (n=60); est2D type II, 14.668.6 (n=59); tor1D
est2D type II, 22.069.1 (n=58).
doi:10.1371/journal.pgen.1000535.g003
15
th,2 0
th, and 25
th restreaks was digested with 4 bp cutter (MspI, HaeIII, HinfI, AluI) for the Southern blot analysis. (Right) Life span of the 1
st,1 0
th, and
25
th restreaks was determined. Average life span of strains shown: BY4742, 24.869.6 (n=59); est2D-type II -1
st P, 16.566.2 (n=57); est2D-type II -10
th
P, 15.067.9 (n=57); est2D-type II -25
th P, 16.167.6 (n=60). (C) Terminal morphology of senescent cells. Cells at the end of life span experiments were
classified according to the budding pattern as described [37]. Average and S.D. values from three independent experiments are shown (n.50 for
each strain in each experiment). (D) a factor responsiveness in old cells. Cells of various ages were scored for their ability to undergo cell cycle arrest
and schmooing in response to the yeast mating pheromone, a factor. The number of cells in each data set for each age group is shown above the bar
and data is presented as the percentage of cells that did not schmoo in the presence of a factor. (E) Life span (right) and telomere length (left)
analysis. Four telomerase components: Est1p, Est2p, Est3p, and TLC1 RNA were co-overexpressed in BCY123 under the control of GAL1 promoter
(Galactose induction). Then cells were serially restreaked on YPD to shut off the over-expression of telomerase. (Left) Telomere blot analysis of the1
st,
2
nd, and 3
rd passaged cells. Genomic DNA was digested with XhoI. (Right) Life span analysis of the 2
nd and 3
rd passaged cells. Average life span of
strains shown: wild-type, 21.866.7 (n=60); 2
nd P, 23.967.5 (n=60); 3
rd P, 23.866.6 (n=60).
doi:10.1371/journal.pgen.1000535.g002
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,25 restreaks, see middle panels of Figure 6A and 6B). These
data suggested that when compared to recombination, telomerase
was the preferred mechanism for telomere maintenance and the
presence of telomerase suppressed telomere-telomere recombi-
nation [22]. Consistent with the results of our mating assay
(Figure 5), the RLS of type II survivors was restored immediately
after the reintroduction of EST2 in spite of the long telomeres
(Figure 6C). Accordingly, a plasmid-borne EST3 restored the life
span of est3D type II survivors immediately after being
transformed (Figure 6D). Reintroduction of a catalytically
inactive est2 (DD670-1AA) into est2D type II survivors, on the
other hand, failed to restore either the telomere length or the
typical life span (Figure 6). These observations suggested that
functional telomerase is required for the life span restoration in
type II survivors.
rDNA recombination is reduced in telomerase-null type II
survivors
In budding yeast, a change of rDNA recombination rate causes
reciprocal changes in the cellular life span. For example,
elimination of the replication block protein FOB1 or over-
expression of SIR2 significantly extended cellular life spans by
reducing rDNA recombination, whereas the deletion of SIR2 had
the opposite effect [51–53]. In the telomerase-null type II
survivors, recombination was presumably activated at the
telomere loci. We wondered whether increased telomere
recombination affected the stability of rDNA loci. A marker loss
assay was performed as described previously [54] to analyze the
rDNA recombination rate in type II survivors. Interestingly, the
rDNA recombination rate in type II survivors was 3-fold lower
than that observed in wild-type cells (Figure 7A), thereby
Figure 4. Replicative life span analysis of yeast cells with different telomere length. (A) Life span analysis of spores immediately dissected
from BY4743 EST2/est2 ::HIS3. Average life span of strains shown (sample size): wild-type, 26.669.1 (n=54); est2D, 27.069.9 (n=54). (B) Life span
(right) and telomere length (left) of wild-type and est2D mutants determined 48 hr growth after tetrad dissection. Average life span of strains shown
(sample size): wild-type, 23.7610.2 (n=60); est2D, 24.3611.0 (n=60). (C) Life span (right) and telomere length (left) of est2D mutants determined 96,
144, or 192 hr growth after tetrad dissection; and the 96 hr, 144 hr passaged est2D cells after transformed with a functional EST2 CEN plasmid.
Average life span of strains shown (sample size): wild-type+Vector, 29.4612.8 (n=60); est2D -96 hr, 12.566.0 (n=80); est2D -144 hr, 7.663.4 (n=68);
est2D -192 hr, 3.561.9 (n=52); est2D -96 hr+EST2, 29.8610.9 (n=59); est2D -144 hr+EST2, 28.7610.2 (n=60).
doi:10.1371/journal.pgen.1000535.g004
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contribute to the acceleration of aging process in type II
survivors.
Like in wild-type cells, deletion of SIR2 in type II survivors led to
a decline of life span from 14.6 to 8.6 generations (Figure 7B).
Unexpectedly, neither the deletion of FOB1 nor introduction of an
extra-copy of SIR2 into type II survivors could extend their life
span (Figure 7C and 7D). Double deletion of FOB1 and SIR2 did
not affect the life span of wild-type cells [53], whereas combined
deletion of FOB1 and SIR2 reduced the life span of type II
survivors (Figure 7E). We were unable to determine why FOB1
deletion or Sir2 over-expression did not positively influence the
RLS of type II survivors. It is possible that the increased telomere
recombination sequestered recombination factors and caused a
reduction in rDNA recombination (Figure 7A). Thus, either FOB1
deletion or Sir2 over-expression could no longer reduce rDNA
recombination levels that were already lower.
Discussion
In this study, we reported that telomerase-null type II survivors,
which employ homologous recombination to efficiently maintain
telomeres, exhibited normal chromosomal stability in an assay that
measures gross chromosomal rearrangement rates, but accelerated
cellular senescence. The reduced replicative life span of type II
cells could be extended by either calorie restriction or inactivation
of the TOR pathway, but not by FOB1 deletion or SIR2 over-
expression. Reintroduction of telomerase restored the life span of
type II survivors to wild-type level, indicating the superiority of
telomerase over homologous recombination in guaranteeing full
replicative potential.
In most eukaryotic species studied so far, telomere replication
involves either telomerase or a recombination pathway [9]. Stable
maintenance of telomeres is required for cell proliferation, survival
and preservation of a species [55]. Reactivation of telomerase or
Figure 5. Life span measurement in type II survivors with the presence and absence of telomerase. (A) Telomere length (left) and life
span (right) analysis. Diploids (named ‘‘survivor diploids’’, a2II+a) were obtained from mating BY4742 est2D type II survivor (MATa) with BY4741
(MATa) wild-type cells. (a+a) refers to wild-type diploids from mating BY4742 (MATa) with BY4741 (MATa). (Left) Genomic DNA was digested with
4 bp cutter (MspI, HaeIII, HinfI, AluI). (Right) Mean life span of strains shown: a+a, 35.1610.9 (n=60); a2II+a, 33.569.6 (n=60). (B) Telomere length
(left) and life span (right) analysis. Spores were dissected from the above ‘‘survivor diploids’’ and their genotypes were determined. (Left) Genomic
DNA was digested with 4 bp cutter (MspI, HaeIII, HinfI, AluI). (Right) Mean life span of strains shown: wild-type, 27.0611.1 (n=60); EST2 spores,
26.868.9 (n=60); est2D spores, 26.8610.1 (n=60).
doi:10.1371/journal.pgen.1000535.g005
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PLoS Genetics | www.plosgenetics.org 8 June 2009 | Volume 5 | Issue 6 | e1000535Figure 6. Reintroduction of telomerase activity restores telomere pattern and life span of the type II survivors. Southern blot analysis
showing the dynamic changes of telomeric DNA in type II survivors after being transformed with EST2 (wild-type), catalytically inactive est2 (DD670-
1AA), or the vector control plasmid. Cells were serially restreaked and genomic DNA from cells obtained after each indicated restreaks (labeled on top
of each panel) was digested with restriction enzyme and probed with a telomere probe. (A) Genomic DNA was digested with XhoI. (B) Genomic DNA
was digested with 4 bp cutter (MspI, HaeIII, HinfI, AluI). (C) Life span analysis of the 1
st restreaked cells after plasmid transformation. Mean life span of
strains shown: BY4742+Vector, 23.369.5 (n=56); est2D type II+EST2, 24.6610.1 (n=58); est2D type II+vector, 12.164.9 (n=59); est2D type II+est2
(DD670-1AA), 12.164.1 (n=60). (D) Life span analysis of strains freshly transformed with EST3 (wild-type) or the vector control plasmid. Mean life span
of strains shown: BY4742+Vector, 29.4612.8 (n=60); est3D type II+EST3, 29.8611.1 (n=60).
doi:10.1371/journal.pgen.1000535.g006
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mammalian cells grown in tissue culture, including human cells
[19,56]. Similarly, the budding yeast S. cerevisiae, can be grown
indefinitely in culture under optimal conditions with either
telomerase or telomere-recombination activated for telomere
maintenance (Figure 1A) [21,22]. However, for a single yeast cell,
its replicative capacity is finite due to the activity of other aging
pathways regardless of how telomeres are maintained throughout
the life span [33,34]. Surprisingly, we found that the budding yeast
type II survivor cells, which have adopted homologous recombi-
nation to replicate their telomeres, possessed shorter replicative life
span (Figure 2 and Figure S1). Type II survivor cells differ from
wild-type cells by the nature of their repetitive telomeric DNA
sequences, the physiological challenges they may face, the length
Figure 7. rDNA recombination is reduced in telomerase-null type II survivor cells. (A) rDNA recombination assay. The upper panel shows
the average recombination rate of three independent isolates with indicated standard deviations. Approximately 20,000–30,000 colonies were
examined for each strain. P values were obtained using student’s t test. The lower panel contains a graph of the average recombination rates and
standard deviations from the upper panel. (B) Life span analysis of est2D type II survivors with SIR2 deletion. Mean life span of strains shown: BY4742,
23.168.6 (n=58); sir2D, 10.363.7 (n=60); est2D type II, 14.668.6 (n=59); sir2D est2D type II, 8.5564.42 (n=53). (C) Life span analysis of est2D type II
survivors with FOB1 deletion. Mean life span of strains shown: BY4742, 25.5610.9 (n=60); fob1D, 35.7612.0 (n=59); est2D type II, 14.668.5 (n=59);
fob1D est2D type II, 13.4610.7 (n=59). (D) Life span analysis of est2D type II survivors with SIR2 over-expression. Mean life span of strains shown:
BY4742, 23.867.6 (n=60); BY4742 SIR2-O.E., 29.0611.2 (n=60); est2D type II, 14.768.0 (n=60); est2D type II SIR2-O.E., 15.968.9 (n=60). (E) Life span
analysis of est2D type II survivors with FOB1 SIR2 double deletion. Mean life span of strains shown: BY4742, 24.369.7 (n=59); fob1D sir2D, 24.869.6
(n=59); est2D type II, 14.267.6 (n=59); fob1D sir2D est2D type II, 9.665.6 (n=59).
doi:10.1371/journal.pgen.1000535.g007
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capping, the heterochromatin structure at these telomeres, and the
telomere recombination status. Since each of these differences
alone or a combination of these differences may be responsible for
the shortened RLS in type II survivors, we examined further the
contributions of these differences in the premature senescence
phenotype.
Compared to wild-type cells, the type II survivors did not
exhibit altered sensitivity to various DNA damage-inducing
reagents (Figure 1B). Additionally, they did not show an increase
in the rate of gross chromosomal rearrangement events (Figure 1F).
Consistent with the genetic assay, type II survivor cells and wild-
type cells displayed identical chromosomal banding patterns when
compared using pulsed-filed gel electrophoresis (Figure 1E).
Moreover, telomere silencing was slightly enhanced in type II
survivors (Figure 1C), and the telomere clustering at the nuclear
periphery remained similar to the wild-type cells (Figure 1D).
These results indicate that the type II survivors are phenotypically
healthy, instead of generally ‘‘sick’’ cells.
When examining cell morphology at the end of the life span,
type II survivor cells showed similar fractions of cells that were
large-budded and small-budded when compared to wild-type cells
at the same stage of life span (Figure 2C). In addition, the type II
survivors exhibited the aging-associated sterility in a manner that
was nearly identical to that of wild type cells (Figure 2D). These
observations on one hand raise the argument that the type II cells
are premature aging instead of premature death, and on the other
hand challenge the idea that the life span reduction of type II
survivors is due to their critically short telomere(s) which could
cause more cells to senesce at G2/M phase (Figure S2).
Additionally, the life span of type II survivors was extended by
calorie restriction or inactivation of the TOR1 pathway (Figure 3),
and reduced by SIR2 deletion (Figure 7B), further supporting the
argument that the type II survivors age prematurely.
Since telomerase has been shown to play a capping function in
maintaining telomere integrity [48], it remains unclear how
telomere capping is maintained in the type II survivors. In the
telomerase deficient pre-survivors with a moderate loss of
telomeric DNA, the defect of telomerase capping due to lack of
Est2p did not detectably affect the replicative capacity (Figure 4A
and 4B). Consistent with those data, the telomerase-null cells
newly derived from EST2/est2 hybrids (crosses between type II
survivors and wild-type haploids) have a comparable life span to
the telomerase proficient cells regardless of the length of their
heterogeneous telomeres (Figure 5B). Thus, the life span reduction
in telomerase-null type II survivors did not appear to be a
consequence of a loss of telomerase capping by Est2p.
Recent studies on the role of telomere length in aging have
expanded from the cellular level to the anatomical/organismal
level. Telomerase-deficient mice with critically short telomeres
exhibit decreased viability associated with diminished proliferative
capacity of B and T cells [57–59]. However, when telomere length
is kept above the critically short length, the relationship between
telomere length and life span seems to be controversial. In
nematode Caenorhabditis elegans, Joeng et al. showed that worms with
longer telomeres live longer [60]; whereas Raices et al. demon-
strated that telomere length contributed little to the normal aging
process [61]. In Drosophila melanogaster, longer telomeres were found
to have no effect on the life span of the adult flies [62]. In the yeast
rif1D cells, long telomeres were proposed to contribute to
accelerated cellular senescence by titrating away limiting pools of
Sir silencing factors from non-telomeric silenced loci [38,39].
Several lines of evidence presented in our current study do not
support the hypothesis that longer telomeres alone contribute to a
shortened life span in yeast. For example, the yeast cells that
harbored long telomeres by temporarily over-expressing telome-
rase exhibited wild-type life span (Figure 2E). Additionally, the
hybrid diploid cells obtained from mating wild-type and type II
haploids had full replicative capacity in spite of heterogeneous long
telomeres (Figure 5A). Moreover, reintroduction of telomerase
slowly restored the telomere-length homogeneity, but immediately
restored the life span (Figure 6). Finally, over-expression of the
essential silencing factor Sir2p had no effect on the replicative life
span of type II survivors (Figure 7D). These results indicate that
long-telomere length per se in the type II survivors is not
associated with the accelerated cellular aging we observed. Most
likely, type II survivors aged prematurely in a telomere-length
independent manner. The results presented in our current work
are different from the ones reported previously [38], where rif1D
or tlc1 mutants were exploited to characterize the relationship
between telomere length and life span. In our experiments
(Figure 2E, Figure 5, and Figure 6), no parameters other than
telomere length have been changed, and this might help to explain
the discrepancy of our results and those reported previously [38].
In contrast to the controversial role of telomere length in
longevity determination, loss of genome integrity is generally
believed to contribute to the finite life span of organisms from
yeast to humans [63]. A causal link between repetitive DNA
instability and aging has been previously established in S. cerevisiae.
The rate of aging in mother cells is dictated by the stability of the
rDNA, which is present in 100–150 tandem arrays of 9.1-kb
repeats [33,64,65]. During the aging of mother cells, extra-
chromosomal rDNA circles (ERCs) are formed by homologous
recombination between rDNA repeats. Importantly, ERCs are
self-replicating via an origin in the rDNA repeat-unit during
subsequent cell cycles and they display biased segregation to
mother cells due to a lack of CEN element [66]. Thus, ERCs
accumulate with the aging of mother cell in a Septin- and Bud6-
dependent manner, and likely contribute to cellular senescence
once a threshold level is reached [67,68]. In type II survivors,
rDNA recombination was decreased compared to the wild-type
cells (Figure 7A). So it is unlikely that the ERCs contributed to the
acceleration of the aging process in type II survivors, and it is likely
that other aging pathway(s) dominated the aging process.
Accordingly, SIR2-overexpression or FOB1-deletion did not
extend RLS in type II survivors because the ERC pathway was
recessive in the aging process of these cells. However, SIR2-
deletion should still further shorten RLS because it makes the
ERC pathway dominant again.
As telomeres are arranged in TG-rich repeats, we could not rule
out the possibility that telomere circles might affect cellular life
span in the same way as rDNA circles. However, qualitative and
quantitative determination of telomeric DNA-containing rings
shows that telomere circles exclusively exist during the time when
survivors are being generated, but not after survivors are
established [69]. In addition, telomere repeats do not contain
self-replicating origin elements. It’s unlikely that telomere circles
would accumulate during the aging process of survivors. Given
that the recombination has been increased at telomeric loci in type
II cells in a manner similar to that of rDNA recombination in
aging cells [70], telomere recombination may titrate away vital
transcription and/or replication factors that play a role in
preventing cellular senescence. Accordingly, we did observe
significantly reduced rDNA recombination in telomerase-null type
II survivors (Figure 7A). However, we could not detect any DNA
replication or repair defect on the general chromosome loci as
shown by several lines of evidence. The telomerase-null type II
survivors did not exhibit altered sensitivity to various DNA
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(Figure 1B), thereby indicating there was no obvious DNA
replication or repair defect on the general chromosome loci. In
addition, the gross-chromosomal rearrangement (GCR) rate was
not increased in type II survivors as previously reported (Figure 1F)
[32]. Moreover, the chromosomal banding pattern of type II
survivors was comparable to the wild-type cells as displayed by
pulsed-field gel electrophoresis (Figure 1E). At this point, we could
not explain why telomeres preferentially competed with the rDNA
loci for recombination. One possibility is that our assays (Figure 1)
are not sensitive enough to detect any replication or repair defect
on the general chromosome loci. Alternatively, both telomeric and
ribosomal DNAs are favorable substrates for certain factor(s), such
as Sir2p binding, and an increase of recombination in either one
would affect the rate of recombination at the other. However,
SIR2 over-expression, which might compensate for the decrease of
Sir2p at rDNA loci, did not extend the replicative life span of type
II survivors (Figure 7D), thereby leading us to propose that at least
Sir2p is not the factor that might be involved in regulating the
relative recombination rates at both telomeres and the rDNA.
The shorter life span of the pre-survivors, which was potentially
caused by severe telomere loss, could be rescued by reintroduction
of telomerase, presumably due to recovery of telomere length by
telomerase (Figure 4C). Interestingly, reintroduction of telomerase
immediately restored the short life span of telomerase-null type II
survivors despite insignificant changes in telomere length (Figure 5
and Figure 6), implying that a distinct mechanism is engaged in
the life span regulation upon reactivation of telomerase.
Reintroduction of telomerase activity caused a gradual shortening
of very long telomeres in type II survivors and eventually re-
established the wild-type telomere Southern blotting banding
pattern (Figure 6A and 6B, middle panels) as previously reported
[22]. This observation suggested that the presence of telomerase
somehow suppressed telomere-telomere recombination. Catalyti-
cally inactive telomerase failed to inhibit telomere recombination
as reflected by the continuous presence of heterogeneous telomere
pattern (Figure 6A and 6B, right panels), thus, it could not
recovery the replicative life span of type II survivors (Figure 6C).
We therefore propose a model where telomere recombination
leads to accelerated cellular aging in telomerase-null survivors and
functional telomerase rescues the replicative life span of type II
survivors by inhibiting telomere recombination. In conclusion,
telomerase has evolved to be as a superior mechanism to telomere
recombination in regulating cellular life span. Telomerase likely
plays a duel role in regulating life span. It helps maintain the
telomeres above the critically short length necessary to reach full
replicative potential, while also inhibiting the telomeric recombi-
nation that otherwise leads to a decline of cellular replicative
capacity.
Materials and Methods
Yeast strains, plasmids, and media
Unless otherwise noted, all yeast strains used in this study were
BY4742 (MATa his3D1 leu2D0 lys2D0 ura3D0), BY4741 (MATa
his3D1 leu2D0 met15D0 ura3D0), BY4743 (MATa/MATa his3D1/
his3D1 leu2D0/leu2D0 lys2D0/+ met15D0/+ ura3D0/ura3D0), and
their derivatives. All strains were grown at 30uC and on YPD
(10 g/L yeast extract, 20 g/L peptone, 2% dextrose) unless
otherwise stated.
tor1D, sir2D and fob1D strains were from EUROSCARF
consortium. est2D was a deletion of the EST2 open reading frame
using a pRS303 plasmid which contained 800 bp homologous
sequences to up- and down-stream of EST2 ORF. The same
method was used for the deletion of the open reading frame of
EST3. sir2D fob1D mutants were obtained by deletion of the SIR2
ORF in the fob1D strain. All gene disruptions were verified by
PCR. Strains over-expressing Sir2p were constructed by genomic
integration of an extra-copy of SIR2. Integration of SIR2 at LEU2
locus was accomplished by transforming cells with Hpa I digested
plasmid pRS305-SIR2. In addition to the entire coding region of
SIR2, 800 nucleotides of up-stream and down-stream sequence
were included. Plasmid pRS305-SIR2 was constructed by ligation
of the PCR-amplified products into the BamH I and Sal I sites of
pRS305.
The pRS316-EST3 centromere plasmid was constructed as
described [71]. The pRS316-EST2 centromere plasmid was a gift
from Dr. Yasumasa Tsukamoto. The pRS316-est2 (DD670-1AA)
was constructed using site-directed mutagenesis method.
Yeast replicative life span analysis
Replicative life span assay of yeast cells was performed as
described previously [72,73]. Prior to analysis, strains were
patched onto fresh solid medium and grown for 2 days at 30uC.
Single colonies were then arrayed onto standard YPD plates using
a micro-manipulator and allowed to grow for about 3 hours.
Virgin daughter cells were isolated as buds from mother cells and
subject to life span analysis. During life span experiments, plates
were incubated at 30uC during the daytime and stored overnight
(,8 hr) at 4uC. Each experiment consisted of more than 50
mother cells and was independently repeated at least twice. Data
shown in the results represent one single experiment. Statistical
significance was determined by a Wilcoxon rank sum test using
Stata 8 software. Differences are stated to be significant when the
confidence is higher than 95%.
Telomere blot
Genomic DNA prepared from each strain was digested by XhoI
or 4 bp cutter (MspI, HaeIII, HinfI, AluI), separated on a 1.0% gel,
transferred to Hybond-N+ membrane (GE Healthcare), cross-
linked by UV and then probed with C1–3A/TG1–3 telomere-
specific probe as described previously [22].
Temperature and DNA damage sensitivity assay
Ten-fold dilutions of each strain were patched on YPD
containing the indicated doses of phleomycin (Sigma), methyl
methanesulfonate (MMS; Sigma), hydroxyurea (HU; Sigma), or
exposed to UV with indicated doses, or grown at 23uC, 30uC, and
37uC. Photos were taken after two days.
Telomere position effect analysis
Each strain that contains URA3-marked telomere VII-L was
grown to log phase at 30uC. Ten-fold serial dilutions were plated
on YC complete medium and YC containing 5-FOA (5-
Fluoroorotic Acid) at 1 g/L. Plates were incubated at 30uC for
two days and then photos were taken.
Immunofluorescence
Immunostaining of Rap1 was performed as described previously
[74].
Pulsed-field gel electrophoresis
Agarose plugs for pulsed-field gel electrophoresis (PFGE) were
prepared as described previously [75]. PFGE was performed on a
Bio-Rad CHEF-DR-III system in 0.56TBE at 14uC using the
following program: step 1, voltage 3.6 V/cm, switch 120 s, time
20 hr; step 2, voltage 3.6 V/cm, switch 300 s, time 24 hr. After
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staining.
Gross chromosomal rearrangement (GCR) assay
GCR rate in indicated strains was determined as previously
described [76]. The nonessential gene, HXT13, located distal to
the CAN1, was replaced with a second selectable marker, the
URA3 gene. Each strain was inoculated into YPD medium and
grown at 30uC until the culture reached saturation. Cells of
suitable dilutions were spread on YC plates in the presence or
absence of 60 mg/L L-canavanine and 1 g/L 5-FOA. A
fluctuation test and the method of the median were used to assess
GCR rate [77].
Determination of a factor responsiveness
Sensitivity to a factor was performed as previously described
[41]. Cells of various ages were scored for their ability to undergo
cell cycle arrest and schmooing in response to the yeast mating
pheromone, a factor. After 4 hours of a factor challenge, cells
were transferred to fresh medium to complete their life span. All
cells documented underwent at least one cell division after being
removed from the presence of a factor.
Determination of rDNA recombination rate
The rate of marker loss in rDNA was measured as described
[54]. Strains carrying a URA3 marker integrated into the rDNA
array were grown in YC medium lacking uracil until the culture
reached saturation. Cells of suitable dilutions were spread on YC
plates with and without 5-FOA. Plates were incubated at 30uC for
two days and colonies were counted. The number of colonies on 5-
FOA plates divided by the number of colonies on YC plates was
reported as the rate of marker loss. A Student’s t test was used to
determine the statistical significance of the data.
Supporting Information
Figure S1 Life span analysis of type II survivors with different
genetic background. (A) Life span curves of est2D type II survivors
in BY4742 (MATa) background. Average life span of strains
shown: BY4742, 24.369.7 (n=59); est2D-type II, 17.666.5
(n=59). (B) Life span curves of est2D type II survivors in W303-
1A (MATa) background. Average life span of strains shown: W303-
1A, 27.269.4 (n=60); est2D-type II, 15.466.4 (n=59). (C) Life
span curves of est3D type II survivors in BY4742 background.
Average life span of strains shown: BY4742, 29.367.4 (n=60);
est3D-type II, 20.068.8 (n=59).
Found at: doi:10.1371/journal.pgen.1000535.s001 (0.35 MB TIF)
Figure S2 Accumulation of G2/M-arrested cells in est2D cells.
(A) The liquid viability assay of est2D mutants. Wild-type and
est2D haploids were picked from a fresh dissecting plate after
48 hr at 30uC. Each colony was inoculated into 5 ml YPDA
liquid culture and grown to saturation (10
8 cells/ml) at 30uC.
Serial passages were initiated with OD600 {similar, tilde operator}
0.05 (7.4610
5 cells/ml), and the cell count was measured by
spectrophotometerevery 24 hr.(B) FACS analysis ofthepercentage
of G2/M-stage cells during the liquid passages. (C) Telomere blot
analysis with cells from the 2
nd,4
th,8
th,1 0
th, and 12
th days in liquid
culture.
Found at: doi:10.1371/journal.pgen.1000535.s002 (1.12 MB TIF)
Figure S3 The liquid viability assay of est2D and est2Dtor1D
mutants. Experimental procedure the same as Figure S2A.
Found at: doi:10.1371/journal.pgen.1000535.s003 (0.06 MB TIF)
Acknowledgments
We thank Yasumasa Tsukamoto, Shu-Chun Teng, and Matt Kaeberlein
for stains and plasmids. We thank Brian A. Lenzmeier and members of
Zhou lab for critical reading and discussion of the manuscript.
Author Contributions
Conceived and designed the experiments: XFC FLM JQZ. Performed the
experiments: XFC. Analyzed the data: XFC JQZ. Wrote the paper: XFC
JQZ.
References
1. Greider CW (1996) Telomere length regulation. Annu Rev Biochem 65:
337–365.
2. Smogorzewska A, de Lange T (2004) Regulation of telomerase by telomeric
proteins. Annu Rev Biochem 73: 177–208.
3. Blackburn EH (2001) Switching and signaling at the telomere. Cell 106:
661–673.
4. de Lange T (2002) Protection of mammalian telomeres. Oncogene 21: 532–540.
5. Kass-Eisler A, Greider CW (2000) Recombination in telomere-length mainte-
nance. Trends Biochem Sci 25: 200–204.
6. Autexier C, Greider CW (1996) Telomerase and cancer: revisiting the telomere
hypothesis. Trends Biochem Sci 21: 387–391.
7. Zakian VA (1995) Telomeres: beginning to understand the end. Science 270:
1601–1607.
8. Biessmann H, Mason JM (1997) Telomere maintenance without telomerase.
Chromosoma 106: 63–69.
9. Lundblad V (2002) Telomere maintenance without telomerase. Oncogene 21:
522–531.
10. Counter CM, Meyerson M, Eaton EN, Weinberg RA (1997) The catalytic
subunit of yeast telomerase. Proc Natl Acad Sci U S A 94: 9202–9207.
11. Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, et al. (1997)
Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276:
561–567.
12. Cohn M, Edstrom JE (1992) Telomere-associated repeats in Chironomus form
discrete subfamilies generated by gene conversion. J Mol Evol 35: 114–122.
13. Pich U, Fuchs J, Schubert I (1996) How do Alliaceae stabilize their chromosome
ends in the absence of TTTAGGG sequences? Chromosome Res 4: 207–213.
14. Roth CW, Kobeski F, Walter MF, Biessmann H (1997) Chromosome end
elongation by recombination in the mosquito Anopheles gambiae. Mol Cell Biol
17: 5176–5183.
15. Mason JM, Biessmann H (1995) The unusual telomeres of Drosophila. Trends
Genet 11: 58–62.
16. Biessmann H, Mason JM, Ferry K, d’Hulst M, Valgeirsdottir K, et al. (1990)
Addition of telomere-associated HeT DNA sequences ‘‘heals’’ broken chromo-
some ends in Drosophila. Cell 61: 663–673.
17. Danilevskaya O, Slot F, Pavlova M, Pardue ML (1994) Structure of the
Drosophila HeT-A transposon: a retrotransposon-like element forming telo-
meres. Chromosoma 103: 215–224.
18. Traverse KL, Pardue ML (1988) A spontaneously opened ring chromosome of
Drosophila melanogaster has acquired He-T DNA sequences at both new
telomeres. Proc Natl Acad Sci U S A 85: 8116–8120.
19. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al. (1994)
Specific association of human telomerase activity with immortal cells and cancer.
Science 266: 2011–2015.
20. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR (1997)
Evidence for an alternative mechanism for maintaining telomere length in
human tumors and tumor-derived cell lines. Nat Med 3: 1271–1274.
21. Lundblad V, Blackburn EH (1993) An alternative pathway for yeast telomere
maintenance rescues est1- senescence. Cell 73: 347–360.
22. Teng SC, Zakian VA (1999) Telomere-telomere recombination is an efficient
bypass pathway for telomere maintenance in Saccharomyces cerevisiae. Mol
Cell Biol 19: 8083–8093.
23. Dunham MA, Neumann AA, Fasching CL, Reddel RR (2000) Telomere
maintenance by recombination in human cells. Nat Genet 26: 447–450.
24. Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, et al. (1999)
Telomerase-negative immortalized human cells contain a novel type of
promyelocytic leukemia (PML) body. Cancer Res 59: 4175–4179.
25. Chen Q, Ijpma A, Greider CW (2001) Two survivor pathways that allow growth
in the absence of telomerase are generated by distinct telomere recombination
events. Mol Cell Biol 21: 1819–1827.
26. Liti G, Louis EJ (2003) NEJ1 prevents NHEJ-dependent telomere fusions in
yeast without telomerase. Mol Cell 11: 1373–1378.
Premature Aging of Telomerase-Null Survivor
PLoS Genetics | www.plosgenetics.org 13 June 2009 | Volume 5 | Issue 6 | e100053527. Mortimer RK, Johnston JR (1959) Life span of individual yeast cells. Nature
183: 1751–1752.
28. Makovets S, Williams TL, Blackburn EH (2008) The telotype defines the
telomere state in Saccharomyces cerevisiae and is inherited as a dominant non-
Mendelian characteristic in cells lacking telomerase. Genetics 178: 245–257.
29. Eugster A, Lanzuolo C, Bonneton M, Luciano P, Pollice A, et al. (2006) The
finger subdomain of yeast telomerase cooperates with Pif1p to limit telomere
elongation. Nat Struct Mol Biol 13: 734–739.
30. Kyrion G, Liu K, Liu C, Lustig AJ (1993) RAP1 and telomere structure regulate
telomere position effects in Saccharomyces cerevisiae. Genes Dev 7: 1146–1159.
31. Renauld H, Aparicio OM, Zierath PD, Billington BL, Chhablani SK, et al.
(1993) Silent domains are assembled continuously from the telomere and are
defined by promoter distance and strength, and by SIR3 dosage. Genes Dev 7:
1133–1145.
32. Pennaneach V, Kolodner RD (2004) Recombination and the Tel1 and Mec1
checkpoints differentially effect genome rearrangements driven by telomere
dysfunction in yeast. Nat Genet 36: 612–617.
33. Sinclair DA, Guarente L (1997) Extrachromosomal rDNA circles–a cause of
aging in yeast. Cell 91: 1033–1042.
34. D’Mello NP, Jazwinski SM (1991) Telomere length constancy during aging of
Saccharomyces cerevisiae. J Bacteriol 173: 6709–6713.
35. Jazwinski SM (1990) Aging and senescence of the budding yeast Saccharomyces
cerevisiae. Mol Microbiol 4: 337–343.
36. AS IJ, Greider CW (2003) Short telomeres induce a DNA damage response in
Saccharomyces cerevisiae. Mol Biol Cell 14: 987–1001.
37. Johnson FB, Marciniak RA, McVey M, Stewart SA, Hahn WC, et al. (2001)
The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere
maintenance in cells lacking telomerase. Embo J 20: 905–913.
38. Austriaco NR Jr, Guarente LP (1997) Changes of telomere length cause
reciprocal changes in the lifespan of mother cells in Saccharomyces cerevisiae.
Proc Natl Acad Sci U S A 94: 9768–9772.
39. Kennedy BK, Gotta M, Sinclair DA, Mills K, McNabb DS, et al. (1997)
Redistribution of silencing proteins from telomeres to the nucleolus is associated
with extension of life span in S. cerevisiae. Cell 89: 381–391.
40. Sinclair DA, Mills K, Guarente L (1997) Accelerated aging and nucleolar
fragmentation in yeast sgs1 mutants. Science 277: 1313–1316.
41. Smeal T, Claus J, Kennedy B, Cole F, Guarente L (1996) Loss of transcriptional
silencing causes sterility in old mother cells of S. cerevisiae. Cell 84: 633–642.
42. Mair W, Dillin A (2008) Aging and survival: the genetics of life span extension by
dietary restriction. Annu Rev Biochem 77: 727–754.
43. Lin SJ, Defossez PA, Guarente L (2000) Requirement of NAD and SIR2 for life-
span extension by calorie restriction in Saccharomyces cerevisiae. Science 289:
2126–2128.
44. Tsuchiya M, Dang N, Kerr EO, Hu D, Steffen KK, et al. (2006) Sirtuin-
independent effects of nicotinamide on lifespan extension from calorie restriction
in yeast. Aging Cell 5: 505–514.
45. Fabrizio P, Pozza F, Pletcher SD, Gendron CM, Longo VD (2001) Regulation
of longevity and stress resistance by Sch9 in yeast. Science 292: 288–290.
46. Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, et al. (2005)
Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 280:
17038–17045.
47. Powers RW 3rd, Kaeberlein M, Caldwell SD, Kennedy BK, Fields S (2006)
Extension of chronological life span in yeast by decreased TOR pathway
signaling. Genes Dev 20: 174–184.
48. Chan SW, Blackburn EH (2002) New ways not to make ends meet: telomerase,
DNA damage proteins and heterochromatin. Oncogene 21: 553–563.
49. Lendvay TS, Morris DK, Sah J, Balasubramanian B, Lundblad V (1996)
Senescence mutants of Saccharomyces cerevisiae with a defect in telomere
replication identify three additional EST genes. Genetics 144: 1399–1412.
50. Kaeberlein M, Kirkland KT, Fields S, Kennedy BK (2005) Genes determining
yeast replicative life span in a long-lived genetic background. Mech Ageing Dev
126: 491–504.
51. Park PU, Defossez PA, Guarente L (1999) Effects of mutations in DNA repair
genes on formation of ribosomal DNA circles and life span in Saccharomyces
cerevisiae. Mol Cell Biol 19: 3848–3856.
52. Defossez PA, Prusty R, Kaeberlein M, Lin SJ, Ferrigno P, et al. (1999)
Elimination of replication block protein Fob1 extends the life span of yeast
mother cells. Mol Cell 3: 447–455.
53. Kaeberlein M, McVey M, Guarente L (1999) The SIR2/3/4 complex and SIR2
alone promote longevity in Saccharomyces cerevisiae by two different
mechanisms. Genes Dev 13: 2570–2580.
54. Kobayashi T, Horiuchi T, Tongaonkar P, Vu L, Nomura M (2004) SIR2
regulates recombination between different rDNA repeats, but not recombination
within individual rRNA genes in yeast. Cell 117: 441–453.
55. Blasco MA (2007) Telomere length, stem cells and aging. Nat Chem Biol 3:
640–649.
56. Henson JD, Neumann AA, Yeager TR, Reddel RR (2002) Alternative
lengthening of telomeres in mammalian cells. Oncogene 21: 598–610.
57. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, et al. (1997)
Telomere shortening and tumor formation by mouse cells lacking telomerase
RNA. Cell 91: 25–34.
58. Lee HW, Blasco MA, Gottlieb GJ, Horner JW 2nd, Greider CW, et al. (1998)
Essential role of mouse telomerase in highly proliferative organs. Nature 392:
569–574.
59. Herrera E, Samper E, Martin-Caballero J, Flores JM, Lee HW, et al. (1999)
Disease states associated with telomerase deficiency appear earlier in mice with
short telomeres. Embo J 18: 2950–2960.
60. Joeng KS, Song EJ, Lee KJ, Lee J (2004) Long lifespan in worms with long
telomeric DNA. Nat Genet 36: 607–611.
61. Raices M, Maruyama H, Dillin A, Karlseder J (2005) Uncoupling of longevity
and telomere length in C. elegans. PLoS Genet 1: e30. doi:10.1371/
journal.pgen.0010030.
62. Walter MF, Biessmann MR, Benitez C, Torok T, Mason JM, et al. (2007) Effects
of telomere length in Drosophila melanogaster on life span, fecundity, and
fertility. Chromosoma 116: 41–51.
63. Burhans WC, Weinberger M (2007) DNA replication stress, genome instability
and aging. Nucleic Acids Res 35: 7545–7556.
64. Philippsen P, Thomas M, Kramer RA, Davis RW (1978) Unique arrangement
of coding sequences for 5 S, 5.8 S, 18 S and 25 S ribosomal RNA in
Saccharomyces cerevisiae as determined by R-loop and hybridization analysis.
J Mol Biol 123: 387–404.
65. Rustchenko EP, Sherman F (1994) Physical constitution of ribosomal genes in
common strains of Saccharomyces cerevisiae. Yeast 10: 1157–1171.
66. Murray AW, Szostak JW (1983) Pedigree analysis of plasmid segregation in
yeast. Cell 34: 961–970.
67. Shcheprova Z, Baldi S, Frei SB, Gonnet G, Barral Y (2008) A mechanism for
asymmetric segregation of age during yeast budding. Nature 454: 728–734.
68. Johnson FB, Sinclair DA, Guarente L (1999) Molecular biology of aging. Cell
96: 291–302.
69. Lin CY, Chang HH, Wu KJ, Tseng SF, Lin CC, et al. (2005) Extrachromosomal
telomeric circles contribute to Rad52-, Rad50-, and polymerase delta-mediated
telomere-telomere recombination in Saccharomyces cerevisiae. Eukaryot Cell 4:
327–336.
70. Sinclair DA, Mills K, Guarente L (1998) Molecular mechanisms of yeast aging.
Trends Biochem Sci 23: 131–134.
71. Yang CP, Chen YB, Meng FL, Zhou JQ (2006) Saccharomyces cerevisiae Est3p
dimerizes in vitro and dimerization contributes to efficient telomere replication
in vivo. Nucleic Acids Res 34: 407–416.
72. Kaeberlein M, Kirkland KT, Fields S, Kennedy BK (2004) Sir2-independent life
span extension by calorie restriction in yeast. PLoS Biol 2: e296. doi:10.1371/
journal.pbio.0020296.
73. Fu XH, Meng FL, Hu Y, Zhou JQ (2008) Candida albicans, a distinctive fungal
model for cellular aging study. Aging Cell 7: 746–757.
74. Gotta M, Laroche T, Formenton A, Maillet L, Scherthan H, et al. (1996) The
clustering of telomeres and colocalization with Rap1, Sir3, and Sir4 proteins in
wild-type Saccharomyces cerevisiae. J Cell Biol 134: 1349–1363.
75. Maringele L, Lydall D (2006) Pulsed-Field Gel Electrophoresis of Budding Yeast
Chromosomes. In: Xiao W, ed. Methods in Molecular Biology: Yeast Protocols.
New Jersey: Humana Press. pp 65–73.
76. Chen C, Kolodner RD (1999) Gross chromosomal rearrangements in
Saccharomyces cerevisiae replication and recombination defective mutants.
Nat Genet 23: 81–85.
77. Lea DE, Coulson CA (1949) The distribution of the number of mutants in
bacterial populations. J Genet 49: 264–285.
Premature Aging of Telomerase-Null Survivor
PLoS Genetics | www.plosgenetics.org 14 June 2009 | Volume 5 | Issue 6 | e1000535